Analysis of the interaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling

European Journal of Endocrinology

Volumn 153, Issue 6, 2005, Pages 949-961

  Miguel, Ricardo Núñez ^a,b   Chen, Shu ^a   Nikfarjam, Laleh ^c   Kominami, Shiro ^c   Carpenter, Byron ^a   Pra, Chiara Dal ^a,d,e   Betterle, Corrado ^e   Zanchetta, Renato ^e   Nakamatsu, Takashi ^a,d   Powell, Michael ^a   Hewer, Rachel ^a   Blundell, Tom L ^b   Smith, Bernard Rees ^a,d   Furmaniak, Jadwiga ^a,d  

^a RSR LTD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c HIROSHIMA UNIVERSITY   (Japan)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCORTICOSTERONE; EPITOPE; MONOCLONAL ANTIBODY; PROGESTERONE DERIVATIVE; STEROID 21 MONOOXYGENASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; BINDING SITES; BINDING SITES, ANTIBODY; EPITOPES; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; SEQUENCE HOMOLOGY, NUCLEIC ACID; STEROID 21-HYDROXYLASE;

EID: 29644436189     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02044     Document Type: Article

References (75)

1. Betterle C, Dal Pra C, Mantero F & Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-364.
2. Wedlock N, Asawa T, Baumann-Antczak A, Rees Smith B & Furmaniak J. Autoimmune Addison's disease. Analysis of auto-antibody binding sites on human steroid 21-hydroxylase. FEBS Letters 1993 332 123-126.
3. Asawa T, Wedlock N, Baumann-Antczak A, Rees Smith B & Furmaniak J. Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. Journal of Clinical Endocrinology and Metabolism 1994 79 372-376.
4. Tanaka H, Asawa T, Powell M, Chen S, Rees Smith B & Furmaniak J. Autoantibody binding to steroid 21-hydroxylase - effect of five mutations. Autoimmunity 1997 26 253-259.
5. Nikoshkov A, Falorni A, Lajic S, Laureti S, Wedell A, Lernmark K & Luthman H. A conformational-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal function domain of human steroid 21-hydroxylase. Journal of Autoimmunity 1999 162 2422-2426.
6. Chen S, Sawicka J, Prentice L, Sanders JF, Tanaka H, Petersen V, Betterle C, Volpato M, Roberts S, Powell M, Rees Smith B & Furmaniak J. Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies. Journal of Clinical Endocrinology and Metabolism 1998 83 2977-2986.
7. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 156-159.
8. Kettleborough CA, Saldanha J, Ansell KH & Bendig MM. Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. European Journal of Immunology 1993 23 206-211.
9. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J & Rees Smith B. Thyroid-stimulating monoclonal antibodies. Thyroid 2002 12 1043-1050.
10. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LDKE, Chirgadze DY, Núñez Miguel R, Blundell TL, Furmaniak J & Rees Smith B. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 2004 14 560-570.
11. Tanaka H, Perez MS, Powell M, Sanders JF, Sawicka J, Chen S, Prentice L, Asawa T, Betterle C, Volpato M, Rees Smith B & Furmaniak J. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. Journal of Clinical Endocrinology and Metabolism 1997 82 1440-1446.
12. Furmaniak J, Kominami S, Asawa T, Wedlock N, Colls J & Rees Smith B. Autoimmune Addison's disease - evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 1994 79 1517-1521.
13. Higuchi A, Kominami S & Takemori S. Kinetic control of steroidogenesis by steroid concentration in guinea pig adrenal microsomes. Biochimica et Biophysica Acta 1991 1084 240-246.
14. White PC, New MI & Dupont B. Structure of human steroid 21-hydroxylase genes. PNAS 1986 83 5111-5115.
15. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W & Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 1997 25 3389-3402.
16. Cosme J & Johnson EF. Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Journal of Biological Chemistry 2000 275 2545-2553.
17. Williams PA, Cosme J, Sridhar V, Johnson EF & McRee DE. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Molecular Cell 2000 5 121-131.
18. Wester MR, Johnson EF, Marques-Soares C, Dansette PM, Mansuy D & Stout CD. Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3Å resolution: evidence for multiple substrate binding modes. Biochemistry 2003 42 6370-6379.
19. Shi J, Blundell TL & Mizuguchi K. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. Journal of Molecular Biology 2001 310 243-257.
20. Mizuguchi K, Deane CM & Blundell TL. HOMSTRAD: a database of protein structure alignments for homologous families. Protein Science 1998 7 2469-2471.
21. deBakker PIW, Bateman A, Burke DF, Miguel RN, Mizuguchi K, Shi J, Shirai H & Blundell TL. HOMSTRAD: adding sequence information to structure-based alignments of homologous protein families. Bioinformatics 2001 17 748-749.
22. Deane CM, Kaas Q & Blundell TL. SCORE: predicting the core of protein models. Bioinformatics 2001 17 541-550.
23. Deane CM & Blundell TL. CODA: a combined algorithm for predicting the structurally variable regions of protein models. Protein Science 2001 10 599-612.
24. Miguel RN, Shi J & Mizuguchi K. Protein fold recognition and comparative modeling using HOMSTRAD, JOY and FUGUE. In Protein Structure Prediction: Bioinformatics Approach. pp 143-169. Ed. I-F Tsigelny, La Jolla, California: International University Line, 2002.
25. Laskowski RA, MacArthur MW, Moss DS & Thornton JM. PROCHECK - a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 1993 26 283-291.
26. Luthy R, Bowie JU & Eisenberg D. Assessment of protein models with 3-dimensional profiles. Nature 1992 356 83-85.
27. Mizuguchi K, Deane CM, Blundell TL, Johnson MS & Overington JP. JOY: protein sequence-structure representation and analysis. Bioinformatics 1998 14 617-623.
28. Gordon LM, Mobley PW, Pilpa R, Sherman MA & Waring AJ. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using C-13-enhanced Fourier transform infrared spectroscopy. Biochimica et Biophysica Acta: Biomembranes 2002 1559 96-120.
29. Sutcliffe MJ, Haneef I, Carney D & Blundell TL. Knowledge based modelling of homologous proteins, part I: three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Engineering 1987 1 377-384.
30. Sali A & Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology 1993 234 779-815.
31. deBakker PIW, DePristo MA, Burke DF & Blundell TL. Ab initio construction of polypeptide fragments: accuracy of loop decoy discrimination by an all-atom statistical potential and the AMBER force field with Generalized Born solvation model. Proteins: Structure, Function and Genetics 2003 51 21-40.
32. DePristo MA, deBakker PIW, Lovell SC & Blundell TL. Ab initio construction of polypeptide fragments: efficient generation of consistent, representative ensembles. Proteins: Structure, Function and Genetics 2003 51 41-55.
33. McDonald IK & Thornton JM. Satisfying hydrogen bonding potential in proteins. Journal of Molecular Biology 1994 238 777-793.
34. Hutchinson EG & Thornton JM. HERA - a program to draw schematic diagrams of protein secondary structures. Proteins 1990 8 203-212.
35. Richmond TJ. Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. Journal of Molecular Biology 1984 178 63-89.
36. Lee B & Richards FM. The interpretation of protein structures: estimation of static accessibility. Journal of Molecular Biology 1971 55 379-400.
37. Jones S & Thornton JM. Principles of protein-protein interactions. PNAS 1996 93 13-20.
38. Nicholls A, Sharp K & Honing B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991 11 281-296.
39. Katchalski-Katzir E, Shariv I, Eisestein M, Friesem AA, Aflalo C & Vakser IA. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. PNAS 1992 89 2195-2199.
40. Sayle RA & Milner-White EJ. RasMol-Biomolecular graphics for all. Trends in Biochemical Sciences 1995 20 374-376.
41. Kabat E, Perry H, Wu T, Gottesman K, Foeller C. Sequences of Proteins of Immunological Interest, edn 5. Bethesda, MD: US Public Health Service, 1991.
42. Graham SE & Peterson JA. How similar are P450s and what can their differences teach us? Archives of Biochemistry and Biophysics 1999 369 24-29.
43. Hofmann K, Bucher P, Falquet L & Bairoch A. The PROSITE database, its status in 1999. Nucleic Acids Research 1999 27 215-219.
44. Miguel RN. Sequence patterns derived from the automated prediction of functional residues in structurally aligned homologous protein families. Bioinformatics 2004 20 2380-2389.
45. Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA & Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 1993 261 731-736.
46. Li H & Poulos TL. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nature Structural Biology 1997 4 140-146.
47. Podust LM, Poulos TL & Waterman MR. Crystal structure of cytochrome P450 14a-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. PNAS 2001 98 3068-3073.
48. Wang M, Roberts DL, Paschke R, Shea TM & Masters BSS. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. PNAS 1997 94 8411-8416.
49. Charbonnier JB, Golinelli-Pimpaneau B, Gigant B, Tawfik DS, Chap R, Schindler DG, Kim SH, Green BS, Eshhar Z & Knossow M. Structural convergence in the active site of a family of catalytic antibodies. Science 1997 275 1140-1142.
50. Kristensen O, Vassylyev DG, Tanaka F, Morikawa K & Fujii I. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1.8 angstrom resolution. Journal of Molecular Biology 1998 281 501-511.
51. Tanner JJ, Komissarov AA & Deutscher SL. Crystal structure of an antigen-binding fragment bound to single-stranded DNA. Journal of Molecular Biology 2001 314 807-822.
52. Keitel T, Kramer A, Wessner H, Scholz W, Schneider-Mergener J & Hohne W. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 1997 91 811-820.
53. Vasudevan S, Tsuruo T & Rose DR. Mode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling study. Journal of Biological Chemistry 1998 25 (273) 413-419.
54. Sawicki MW, Ng PC, Burkhart BM, Pletnev VZ, Higashiyama T, Osawa Y & Ghosh D. Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody-antigen interactions. Molecular Immunology 1999 36 423-432.
55. Fotinou C, Beauchamp J, Emsley P, deHaan A, Schielen WJG, Bos E & Isaacs NW. Structure of an Fab fragment against a C-terminal peptide of hCG at 2.0Å resolution. Journal of Biological Chemistry 1998 22 (273) 515-518.
56. Suh SW, Bhat TN, Navia MA, Cohen GH, Rao DN, Rudikoff S & Davies DR. The galactan-binding immunoglobulin Fab J539: an x-ray diffraction study at 2.6-Å resolution. Proteins 1986 1 74-80.
57. Rini JM, Schulze-Gahmen U & Wilson IA. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 1992 255 959-965.
58. Oliver CF, Modi S, Primrose WU, Lian LY & Roberts GCK. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450BM3: hydroxylation of alkyl trimethylammonium compounds. Biochemical Journal 1997 327 537-544.
59. Graham-Lorence S, Amarneh B, White RE, Peterson JA & Simpson ER. A three-dimensional model of aromatase cytochrome P450. Protein Sciences 1995 4 1065-1080.
60. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding sequences. Journal of Biological Chemistry 1992 267 83-90.
61. Sevrioukova IF, Li H, Zhang H, Peterson JA & Poulos TL. Structure of a cytochrome P450-redox partner electron-transfer complex. PNAS 1999 96 1863-1868.
62. Lin D, Zhang LH, Chiao E & Miller WL. Modelling and mutagenesis of the active site of human P450c17. Molecular Endocrinology 1994 8 392-402.
63. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacology Reviews 1989 40 243-288.
64. Auchus RJ & Miller WL. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects on mutations. Molecular Endocrinology 1999 13 1169-1182.
65. Lewis DFV & Lee-Robichaud P. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure. Journal of Steroid Biochemistry and Molecular Biology 1998 66 217-233.
66. Mornet E & Gibrat J-F. A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations. Human Genetics 2000 106 330-339.
67. Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D & Jhoti H. Crystal structure of human cytochrome P450 2c9 with bound warfarin. Nature 2003 424 464-468.
68. Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD & Johnson EF. Structure of human microsomal cytochrome P450 2c8. Evidence for a peripheral fatty acid binding site. Journal of Biological Chemistry 2004 279 9497-9503.
69. Jukes TH & King JL. Evolutionary nucleotide replacements in DNA. Nature 1979 281 605-606.
70. Glockshuber R, Schmidt T & Pluckthun A. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. Biochemistry 1992 31 1270-1279.
71. Rudikoff S & Pumphrey JG. Functional antibody lacking a variable-region disulfide bridge. PNAS 1986 83 7875-7878.
72. Ward VK, Schneider PG, Kreissing SB, Hammock BD & Choudary PV. Cloning, sequencing and expression of the Fab fragment of a monoclonal antibody to the herbicide atrazine. Protein Engineering 1993 6 981-988.
73. Padlan EA. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 1990 7 112-124.
74. Fellouse FA, Wiesmann C & Sidhu SS. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. PNAS 2004 101 12467-12472.
75. Nikfarjam L, Kominami S, Yamazaki T, Chen S, Hewer R, Dal Pra C, Nakamatsu T, Betterle C, Zanchetta R, Rees Smith B & Furmaniak J. Mechanism of inhibition of cytochrome P450 C21 enzyme activity by autoantibodies from patients with Addison's disease. European Journal of Endocrinology 2005 152 95-101.